Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial

Rationale: Aspirin-exacerbated respiratory disease is characterized by severe asthma, nonsteroidal antiinflammatory drug hypersensitivity, nasal polyposis, and leukotriene overproduction. Systemic corticosteroid therapy does not completely suppress lifelong aspirin hypersensitivity. Omalizumab effic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Respir Crit Care Med
Autori principali: Hayashi, Hiroaki, Fukutomi, Yuma, Mitsui, Chihiro, Kajiwara, Keiichi, Watai, Kentaro, Kamide, Yosuke, Nakamura, Yuto, Hamada, Yuto, Tomita, Yasuhiro, Sekiya, Kiyoshi, Tsuburai, Takahiro, Izuhara, Kenji, Wakahara, Keiko, Hashimoto, Naozumi, Hasegawa, Yoshinori, Taniguchi, Masami
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Thoracic Society 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301746/
https://ncbi.nlm.nih.gov/pubmed/32142372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1215OC
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi